|
|
Feasibility analysis of Yiqi Yangyin Xiaozheng Tongluo in treating early diabetic nephropathy |
JIANG Guo |
The First Internal Medicine,the Eighth Hospital of Changsha City in Hunan Province,Changsha 410100,China |
|
|
Abstract ObjectiveTo explore effect of Yiqi Yangyin Xiaozheng Tongluo in treating early diabetic nephropathy. Methods 56 patients with diabetic nephropathy in our hospital from February 2013 to February 2016 were selected and divided into experimental group and control group according to admission order,and each group was 28 cases.On the basis of routine treatment of diabetic,patients in the control group were given Irbesartan Tablet and traditional Chinese medicine placebo,and patients in the experimental group were given Yiqi Yangyin Xiaozheng Tongluo Decoction.Blood glucose index,changes of renal function and effects difference between two groups were compared.Results Total effective rate in the experimental group was 92.86%,obvious better than 71.43%in the control group (P<0.05).After treatment,all of FBS,2 h PBG,HbA1c and UAER in two groups decreased obviously compared with before treatment(P<0.05),while the index between two groups had no obvious difference after treatment(P>0.05).After treatment,level of BUN in two groups had no obvious difference compared with before treatment(P>0.05);there was no significant difference in BUN level after treatment between two groups(P>0.05).Level of SCr in the experimental group and the control group was respectively(69.33±10.13)μmol/L and(73.98±10.07)μmol/L,and the difference was obvious(P<0.05);level of SCr in the experimental group was significantly improved after treatment than before treatment(P<0.05).Conclusion In treating diabetic nephropathy,Yiqi Yangyin Xiaozheng Tongluo Decoction and Irbesartan have similar effect on patients′blood glucose and renal function,but curative effect is relatively obvious and suitable for clinical use.
|
|
|
|
|
[1] |
魏欣,王晶,刘月.厄贝沙坦对糖尿病肾病患者的影响[J].中国当代医药,2014,21(33):68-69.
|
[2] |
李慧,方敬爱,张晓东.益肾胶囊对糖尿病肾病大鼠肾组织TGF-β1及Smad7表达的影响[J].中国中西医结合肾病杂志,2014,15(3):194-196.
|
[3] |
孙超,谢晴宇,孟庆刚.糖尿病肾病中医证素分布规律研究[J].北京中医药大学学报,2015,38(4):266-270.
|
[4] |
刁永书,黄佑群,马登艳,等.糖尿病肾脏疾病住院患者初诊时的临床分析及护理[J].四川医学,2014,35(4):506-509.
|
[5] |
郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.
|
[6] |
秦测.替米沙坦联合螺内酯治疗早期糖尿病肾病的效果观察[J].中国当代医药,2014,21(3):58-59.
|
[7] |
徐艳秋,黄芳,王怡.因虚致瘀理论与糖尿病肾病[J].中医药学报,2014,42(1):7-8.
|
[8] |
奚悦,李敬林.益气活络方对早期2型糖尿病肾病患者的临床疗效[J].中国医科大学学报,2013,42(6):485-487.
|
[9] |
孙毅,张勉之.补肾活血法治疗糖尿病肾病临床期的疗效观察[J].北京中医药大学学报,2013,36(5):353-356.
|
[10] |
闫玲,侯建芳.中西医结合治疗早期糖尿病肾病临床观察[J].中国中医急症,2014,23(5):951-952.
|
[11] |
夏磊,陈洪宇.糖尿病肾病的中医药治疗[J].安徽中医药大学学报,2015,34(1):94-96.
|
[12] |
杨若愚.中西医结合治疗糖尿病肾病临床研究[J].中医学报,2015,34(7):963-965.
|
[13] |
陈志强,方敬,王月华,等.益气养阴消癥通络中药治疗早期糖尿病肾病的临床观察[J].中国中西医结合肾病杂志,2015,16(11):962-964.
|
[14] |
李永国,戴国军.中西医结合治疗早期糖尿病肾病疗效观察[J].现代中西医结合杂志,2014,24(16):688.
|
[15] |
胡钢,李鸣,官艳华.中西医结合治疗早期糖尿病肾病30例临床研究[J].江苏中医药,2015,47(10):28-29.
|
[16] |
刘伟敬,梁碧婵,胡海滢,等.“益气养阴通络法”通过调控SIRT1延缓糖尿病肾病进展的研究[J].中国中西医结合肾病杂志,2013,14(3):198-202.
|
|
|
|